ARTICLE | Distillery Therapeutics
Neurology
November 2, 2016 11:11 PM UTC
Patient sample, cell culture and mouse studies suggest inhibiting NUAK1 could help treat AD, PSP and other tauopathies. In postmortem samples of tau-enriched brain fractions from AD and PSP patients, ...
BCIQ Company Profiles